{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:11:18Z","timestamp":1778227878550,"version":"3.51.4"},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Die Bestimmungen von Thyreoglobulin (TG) im Serum\/Plasma und die Ultraschall-untersuchung des Halses sind derzeit die Hauptpfeiler der postoperativen \u00dcberwachung von Patienten mit differenzierten Schilddr\u00fcsenmalignomen (DTC). TG kann bei diesen Patienten unter notwendiger Levothyroxin-Medikation in TSH-supprimierender Dosierung als Tumormarker bestimmt werden. Die immunologische TG-Bestimmung als Laborparameter ist in der Schilddr\u00fcsenmalignom-Nachsorge immer an eine Best\u00e4tigung des Testergebnisses gebunden, um interferierende St\u00f6rgr\u00f6\u00dfen zu erkennen. Hierzu gibt es zwei h\u00e4ufig eingesetzte M\u00f6glichkeiten: erstens die TG-Wiederfindungsrate (Recovery) und zweitens die Bestimmung von Anti-TG-Autoantik\u00f6rpern (TGAk). Beide Tests l\u00f6sen aber das Problem der richtigen TG-Bestimmung nur unzureichend. Eine weitere wichtige St\u00f6rm\u00f6glichkeit sind heterophile Antik\u00f6rper. Die massenspektroskopische TG-Bestimmung ist eine aufwendigere Alternative, die in unklaren F\u00e4llen genutzt werden kann.<\/jats:p>","DOI":"10.1055\/a-2714-3060","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T23:38:59Z","timestamp":1768952339000},"page":"116-122","source":"Crossref","is-referenced-by-count":0,"title":["Thyreoglobulin"],"prefix":"10.1055","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6056-6829","authenticated-orcid":false,"given":"Eleonore","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Medizinische Forschung, Medizinische Universit\u00e4t Graz, Graz, \u00d6sterreich"},{"name":"Institut f\u00fcr Klinische Chemie und Pathobiochemie, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Wahl","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Klinische Chemie und Pathobiochemie, Universit\u00e4t T\u00fcbingen, T\u00fcbingen, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"ref1","first-page":"489","article-title":"The release of thyroglobulin from the thyroid gland into thyroid lymphatics; the identification of thyroglobulin in the thyroid lymph and in the blood of monkeys by physical and immunological methods and its estimation by radioimmunoassay","volume":"12","author":"PM Daniel","year":"1967","journal-title":"Immunology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/105072502760258686","article-title":"Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma","volume":"12","author":"A Bachelot","year":"2002","journal-title":"Thyroid"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/hed.21214","article-title":"Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinoma","volume":"32","author":"L Giovanella","year":"2010","journal-title":"Head Neck"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/s0748-7983(97)92292-7","article-title":"The dynamics of serum thyroglobulin elimination from the body after thyroid surgery","volume":"23","author":"M Hocevar","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0038-1632259","article-title":"Impact of serum thyroglobulin concentration on the diagnosis of benign and malignant thyroid diseases","volume":"39","author":"T Rink","year":"2000","journal-title":"Nuklearmedizin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/eje.1.01940","article-title":"Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy","volume":"153","author":"R G\u00f6rges","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaoto.2014.264","article-title":"Measuring the extent of total thyroidectomy for differentiated thyroid carcinoma using radioactive iodine imaging: relationship with serum thyroglobulin and clinical outcomes","volume":"140","author":"FC Holsinger","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1046\/j.1365-2265.2003.01681.x","article-title":"Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease","volume":"58","author":"LM Demers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/eje-14-0148","article-title":"Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper","volume":"171","author":"L Giovanella","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1093\/ejendo\/lvad109","article-title":"Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus","volume":"189","author":"L Giovanella","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/thy.1993.3.213","article-title":"Basal and thyrotropin-stimulated secretion rates of thyroglobulin from the human thyroid gland during surgery","volume":"3","author":"L Tegler","year":"1993","journal-title":"Thyroid"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/(sici)1096-9896(199905)188:13.0.Co;2-5","article-title":"TSH receptor status of thyroid neoplasms \u2013 TaqMan RT-PCR analysis of archival material","volume":"188","author":"OM Sheils","year":"1999","journal-title":"J Pathol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-0038-1649554","article-title":"Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma","volume":"57","author":"FA Verburg","year":"2018","journal-title":"Nuklearmedizin"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/thy.2010.0355","article-title":"Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy","volume":"21","author":"A Miyauchi","year":"2011","journal-title":"Thyroid"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"BR Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1515\/cclm-2021-1046","article-title":"Thyroglobulin and thyroglobulin antibodies: assay-dependent management consequences in patients with differentiated thyroid carcinoma","volume":"60","author":"CMJ van Kinschot","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases","volume":"8","author":"E Fr\u00f6hlich","year":"2017","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-139-5_part_1-200309020-00010","article-title":"Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens","volume":"139","author":"L Chiovato","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1515\/cclm-2018-1390","article-title":"Measuring thyroglobulin in patients with thyroglobulin autoantibodies: evaluation of the clinical impact of BRAHMS Kryptor Tg-minirecovery test in a large series of patients with differentiated thyroid carcinoma","volume":"57","author":"L Giovanella","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1089\/thy.2017.0052","article-title":"Effect of Thyroglobulin Autoantibodies on the Metabolic Clearance of Serum Thyroglobulin","volume":"28","author":"F Latrofa","year":"2018","journal-title":"Thyroid"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cll.2004.01.003","article-title":"Interferences in hormone immunoassays","volume":"24","author":"GG Klee","year":"2004","journal-title":"Clin Lab Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"N Bolstad","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1210\/jc.2003-030122","article-title":"Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays","volume":"88","author":"CM Preissner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1055\/s-0030-1254132","article-title":"Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients","volume":"42","author":"FA Verburg","year":"2010","journal-title":"Horm Metab Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1210\/jc.2012-4172","article-title":"Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry","volume":"98","author":"AN Hoofnagle","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ncpendmet0757","article-title":"Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer","volume":"4","author":"CA Spencer","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1515\/cclm-2021-1288","article-title":"Interferences in immunoassays: review and practical algorithm","volume":"60","author":"L Wauthier","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2310\/JIM.0b013e318276deb4","article-title":"A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies","volume":"60","author":"NJ Clarke","year":"2012","journal-title":"J Investig Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"E1074","DOI":"10.1210\/jc.2015-1967","article-title":"Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes","volume":"100","author":"BC Netzel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1515\/cclm-2014-0813","article-title":"Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges","volume":"53","author":"L Giovanella","year":"2015","journal-title":"Clin Chem Lab Med"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2714-3060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:23:47Z","timestamp":1778225027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2714-3060"}},"subtitle":["Ein wichtiger Tumormarker und eine Herausforderung f\u00fcr Labor und Klinik"],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2026,1,20]]},"published-print":{"date-parts":[[2026,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2714-3060","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}